{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:30:01Z","timestamp":1774949401917,"version":"3.50.1"},"reference-count":20,"publisher":"SLACK, Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychosoc Nurs Ment Health Serv"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>\n            The United States is facing a major crisis with the current opioid epidemic. Tens of thousands of individuals are dying each year due to abuse and misuse of heroin and prescription opiate drugs. Nurses play an integral role in these aspects of health care and offer solutions by providing education; preventive measures; treatments, including medication-assisted treatments (MATs); and ongoing recovery options for individuals with opioid use disorders. Nurses provide education, issue prescriptions and dispense medications, and provide overall physical and mental health care to patients struggling with this \u201cdisease of the brain,\u201d and with the signing of the Comprehensive Addiction and Recovery Act, advanced practice RNs will soon be able to include MATs related to buprenorphine as part of their treatment plan. The current article explores the anatomy, physiology, and genetics of addiction and how they relate to the pharmacological MATs used to treat opioid use disorders. [\n            <jats:italic>Journal of Psychosocial Nursing and Mental Health Services, 55<\/jats:italic>\n            (1), 18\u201323.]\n          <\/jats:p>","DOI":"10.3928\/02793695-20170119-03","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T20:52:32Z","timestamp":1485809552000},"page":"18-23","source":"Crossref","is-referenced-by-count":6,"title":["The Opioid Epidemic: What Does it Mean for Nurses?"],"prefix":"10.3928","volume":"55","author":[{"given":"Laura G.","family":"Leahy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.03.007"},{"key":"e_1_3_1_3_1","unstructured":"Center for Behavioral Health Statistics and Quality. (2016). Results from the 2015 national survey on drug use and health: Detailed tables . Retrieved from https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabs-2015\/NSDUH-DetTabs-2015\/NSDUH-DetTabs-2015.pdf"},{"key":"e_1_3_1_4_1","unstructured":"Centers for Disease Control and Prevention. (2016). About underlying cause of death 1999\u20132015 . Retrieved from http:\/\/wonder.cdc.gov\/ucd-icd10.html"},{"key":"e_1_3_1_5_1","unstructured":"Comprehensive Addiction and Recovery Act of 2016 S. 524 114th Cong. (2015\u20132016)."},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000075"},{"issue":"1","key":"e_1_3_1_7_1","first-page":"18","article-title":"Mu opioid receptor gene: New point mutations in opioid addicts","volume":"5","author":"Dinarvand A.","year":"2014","unstructured":"Dinarvand A., Goodarzi A., Vousooghi N., Hashemi M., Dinarvand R., Ostadzadeh F., Zarrindast M.R. (2014). Mu opioid receptor gene: New point mutations in opioid addicts. Basic Clinical Neuroscience, 5(1), 18\u201321.","journal-title":"Basic Clinical Neuroscience"},{"key":"e_1_3_1_8_1","unstructured":"Drug Enforcement Agency. (2016). 2015 National drug threat assessment summary . Retrieved from https:\/\/www.dea.gov\/docs\/2015%20NDTA%20Report.pdf"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.4.652"},{"key":"e_1_3_1_10_1","unstructured":"Murthy V.H. (2016). Facing addiction in America: The Surgeon General's report on alcohol drugs and health executive summary: Preface . Retrieved from https:\/\/addiction.surgeongeneral.gov\/executive-summary.pdf"},{"key":"e_1_3_1_11_1","volume-title":"Principles of drug addiction treatment: A research-based guide","author":"National Institute on Drug Abuse","year":"2012","unstructured":"National Institute on Drug Abuse. (2012). Principles of drug addiction treatment: A research-based guide. Rockville, MD: National Institutes of Health, U.S. Department of Health and Human Services."},{"key":"e_1_3_1_12_1","unstructured":"National Institute on Drug Abuse. (2015). Overdose death rates . Retrieved from http:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates"},{"key":"e_1_3_1_13_1","unstructured":"QuintilesIMS Institute. (2016). Medicines use and pending in the U.S.: A review of 2015 and outlook to 2020 . Retrieved from http:\/\/www.imshealth.com\/en\/thought-leadership\/quintilesims-institute\/reports\/medicines-use-and-spending-in-the-us-a-review-of-2015-and-outlook-to-2020#form"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001386"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1792-04.2005"},{"key":"e_1_3_1_16_1","volume-title":"Federal guidelines for opioid treatment programs","author":"Substance Abuse and Mental Health Services Administration","year":"2015","unstructured":"Substance Abuse and Mental Health Services Administration. (2015). Federal guidelines for opioid treatment programs. Rockville, MD: Author."},{"key":"e_1_3_1_17_1","unstructured":"Substance Abuse and Mental Health Services Administration. (2016). Medication-assisted treatment of opioid use disorder: Pocket guide . Retrieved from http:\/\/store.samhsa.gov\/product\/Medication-Assisted-Treatment-of-Opioid-Use-Disorder-Pocket-Guide\/Most-Popular\/SMA16-4892PG?sortByValue=4"},{"key":"e_1_3_1_18_1","unstructured":"U.S. Department of Health and Human Services. (2016). Facing addiction in America: The Surgeon General's report on alcohol drugs and health . Retrieved from https:\/\/addiction.surgeongeneral.gov\/executive-summary.pdf"},{"key":"e_1_3_1_19_1","unstructured":"U.S. Department of Justice National Drug Intelligence Center. (2011). National drug threat assessment 2011 . Retrieved from https:\/\/www.justice.gov\/archive\/ndic\/pubs44\/44849\/44849p.pdf"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P759"},{"issue":"2","key":"e_1_3_1_21_1","first-page":"1","article-title":"Deaths: Final data for 2013","volume":"64","author":"Xu J.","year":"2016","unstructured":"Xu J., Murphy S.L., Kochanek K.D., Bastian B.A. (2016). Deaths: Final data for 2013. National Vital Statistics Reports, 64(2), 1\u2013119.","journal-title":"National Vital Statistics Reports"}],"container-title":["Journal of Psychosocial Nursing and Mental Health Services"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/psychiatry\/journals\/jpn\/2017-1-55-1\/%7Bc0a77f44-402a-4a4d-af63-ea7d9cfb31de%7D\/the-opioid-epidemic-what-does-it-mean-for-nurses","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T17:37:40Z","timestamp":1683049060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/02793695-20170119-03"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3928\/02793695-20170119-03"],"URL":"https:\/\/doi.org\/10.3928\/02793695-20170119-03","relation":{},"ISSN":["0279-3695","1938-2413"],"issn-type":[{"value":"0279-3695","type":"print"},{"value":"1938-2413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}